The important progress and breakthrough of modern biotechnology is accelerating its penetration into the application field, and its strategic position in leading the future economic and social development is becoming increasingly prominent. Global research funding in life sciences has grown rapidly, from US$124.7 billion in 2016 to US$157.6 billion in 2020, with a compound annual growth rate of 6.0%. At the same time, with China’s emphasis on the field of life sciences and the continuous improvement and improvement of the construction of scientific and technological innovation systems, China’s research capital investment in the field of life sciences has also continued to increase, from 49.6 billion yuan in 2016 to 97.8 billion yuan in 2020. The proportion of RMB in research funding in the global life science field has also increased from 6.0% in 2016 to 9.0% in 2020.
In the past few hundred years, the development of the field of life science has experienced a continuous in-depth process from the tissue to the cellular, subcellular and molecular level and even the level of systems biology. The landmark discovery of the DNA double helix structure marks that the research level of life science has entered the era of molecular biology. So far, molecular biology has become one of the fastest-growing and most cutting-edge fields in the life sciences. Nucleic acids and proteins are the main objects of molecular biology research, especially the omics research on nucleic acids and proteins has become a popular research direction in recent years. . With the development of purification and testing technology and the increase of testing demand, systems biology has effectively combined popular disciplines such as genomics and proteomics to promote the development of technology. As an important basic raw material for life science experiments, biological reagents inevitably accompany the development of the life science field.
The global bioreagent research market size was US$13.9 billion in 2016, and will grow to US$18.2 billion in 2020 at a compound annual growth rate of 6.92%. This investment is expected to reach a scale of US$27.2 billion in 2025, with a compound annual growth rate of 8.40% from 2020 to 2025.
The scale of China’s biological reagent scientific research market reached RMB 8.2 billion in 2016, and it will grow at a compound annual growth rate of 16.51% to RMB 15.1 billion in 2020, which is higher than the global biological reagent scientific research market in the same period. This investment is expected to reach a scale of RMB 34.6 billion in 2025, with a compound annual growth rate of 18.10% during the period.
The biological reagent scientific research market can be divided into industrial scientific research users and scientific research institution users according to user types. In 2020, users of scientific research institutions accounted for 61.6% of the global biological reagent research market. During the same period, in the Chinese market, users of scientific research institutions accounted for 67.3%, and the proportion of users of scientific research institutions was higher than that of industrial scientific research users. In addition, China’s biological reagent research market can be divided into three types: cells, proteins and molecules according to the type of reagents, of which molecular biological reagents account for the highest proportion, accounting for 50.5%.
To view the full report click here
Note: The articles on this site have not been posted and shared by netizens or institutions unless they are marked as original. If there is any need for publicity or infringement, please contact [email protected].
This article is reprinted from: https://www.dx2025.com/archives/170378.html
This site is for inclusion only, and the copyright belongs to the original author.